Instil Bio(TIL)
DALLAS, TXBiotechnology
Focus: Instil Bio is a Dallas-based cell therapy company focused on developing TIL (tumor-infiltrating lymphocyte) and other cell-based immunotherapies for oncology. Public since 2008 with a lean, early-stage pipeline.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
8+8 this month
Growing — net +8 jobs in 30d
12 jobs added vs 4 removed. Steady team buildout.
Should You Work at Instil Bio?
AI assessmentHigh-risk, high-reward early-stage cell therapy play suitable only for researchers willing to tolerate significant financial instability and potential company restructuring.
Why Work Here
- Working in cutting-edge cell therapy modality with direct impact on oncology patients and emerging scientific field
- Public company status provides liquidity upside and institutional credibility absent in many pre-revenue biotech peers
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Help build intelligence for Instil Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.